Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Nephron. Clinical Practice|June 24, 2009
Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fearsZhiguo Mao, Albert C M OngACS Omega|October 18, 2021
Controls on Organic Matter Accumulation of the Triassic Yanchang Formation Lacustrine Shales in the Ordos Basin, North ChinaXiaoliang Chen, Bin Zhang, Haiping Huang, et al.Frontiers in Cell and Developmental Biology|August 29, 2025
Protein lactylation in kidney diseasesYelei Xu, Xinming Li, Zhiguo Mao, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2014
Metabolic abnormalities in autosomal dominant polycystic kidney diseaseZhiguo Mao, Guoqiang Xie, Albert C M OngF1000Research|September 6, 2016
Autosomal dominant polycystic kidney disease: recent advances in clinical managementZhiguo Mao, Jiehan Chong, Albert C M OngClinical Kidney Journal|July 5, 2021
Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazoneZhiguo Mao, Manoj K Valluru, Albert C M OngAmerican Journal of Physiology. Renal Physiology|March 25, 2011
Thiazolidinediones inhibit MDCK cyst growth through disrupting oriented cell division and apicobasal polarityZhiguo Mao, Andrew J Streets, Albert C M OngFrontiers in Nephrology|September 7, 2023
Plant-derived compounds for treating autosomal dominant polycystic kidney diseaseJieting Zhang, Jiaxin Chen, Jing Xu, et al.Biochemistry and Biophysics Reports|March 24, 2025
Alterations of renal polyamine metabolism in mice with folic acid-induced chronic kidney diseaseCheng Xue, Jiaxin Chen, Xinming Li, et al.BMC Nephrology|September 28, 2013
Complete staghorn calculus in polycystic kidney disease: infection is still the causeZhiguo Mao, Jing Xu, Chaoyang Ye, et al.Pageof 9